Paper Highlights Best Practices for Omega-3 Trials with Cardiovascular Outcomes

A paper published this week in the journalProstaglandins, Leukotrienes and Essential Fatty Acids sheds new light on recent neutral studies questioning the benefits of omega-3s for heart health. The paper titled, "Conducting Omega-3 Clinical Trials with Cardiovascular Outcomes: Proceedings of a Workshop Held at ISSFAL 2014," identifies experimental design issues in recent studies that have not demonstrated significant effects of EPA and DHA omega-3s on cardiovascular disease outcomes and suggests that it is too early to conclude that EPA and DHA do not provide cardiovascular health benefits.

All Press Releases

GOED In The News
Recent Tweets - @GOEDOmega3